Early publications on open innovation identified two syndromes that would prevent companies from adequately adopting open innovation, the NIH (not-invented-here) syndrome, related to the unwillingness to use external knowledge, and the NSH (not-sold-here) syndrome, connected to a negative attitude towards the external commercialization of knowledge assets. Despite these early definitions, current research on the topic has been mostly focused on the absorptive capacity perspective, and less attention has been given to other relevant factors, culture being among them. This chapter addresses this issue, by proposing a regression model that correlates the presence of these syndromes with open innovation organization and the practice of inbound and outbound open innovation. Some of the hypotheses in this model are confirmed, mostly on the side of inbound open innovation, when tested with data from a questionnaire-based survey on the extent of the use of open innovation practices and open business modes in the Canadian aerospace industry.
You are not authenticated to view the full text of this chapter or article.
Get access to the full article by using one of the access options below.